APP下载

鼻咽癌转移相关分子标志物的研究进展

2015-06-17詹德超余忠华

中国现代医生 2015年13期

詹德超 余忠华

[摘要] 鼻咽癌是一种来源于鼻黏膜上皮细胞的恶性肿瘤,是我国南方常见的恶性肿瘤之一。鼻咽癌大多数为低分化癌,恶性程度较高,易发生远处转移。国内外研究表明,肿瘤的侵袭和转移与细胞的异常运动有关,是肿瘤细胞的粘附、降解、运动以及血管生成等多种生物学行为互相作用的动态过程。但是NPC浸润转移的分子机制至今尚未完全阐明。随着现代分子生物学的发展,越来越多鼻咽癌转移的相关分子标志物逐渐被发现。深入了解这些分子标志物的表达及调控,筛选出对鼻咽癌具有较高敏感性、特异性并可进行早期诊断及评估预后的标记物,寻找出药物新靶点进行针对性更强的抗肿瘤治疗具有十分重要的意义。本研究拟对鼻咽癌转移相关分子标志物的研究进展做一综述。

[关键词] 鼻咽癌;转移;分子标志物

[中图分类号] R739.63 [文献标识码] A [文章编号] 1673-9701(2015)13-0147-06

[Abstract] Nasopharyngeal carcinoma is a malignant neoplasm which arises from the mucosal epithelium cells of the nasopharynx,it is also one of the common malignant tumors in southern China. Most nasopharyngeal carcinomas are poorly differentiated carcinomas. Nasopharyngeal carcinomas are high degree of malignancy,which prone to distant metastasis.The invasion and metastasis of neoplasm are associated with the perverted movement of cells,which is a dynamic process of biologic behavior interactions among adhesion,degradation and angiogenesis in cancer cells. However, the molecular mechanisms underlying NPC invasion and metastasis have not fully elucidated. With the development of Modem molecular biology,more and more new molecular markers in NPC,such as biomarkers have been gotten to know the related molecules expression and molecular regulation, which play important roles in screening tumor markers with more high sensitivity and specificity,achieving early diagnosis ,predicting treatment prognoses and providing new therapeutic strategies to make it more pertinent in anti-tumor therapy. This study is aimed to review the research progress of molecular marker in metastasis of nasopharyngeal carcinoma.

[Key words] Nasopharyngeal carcinoma;Metastasis;Molecular marker

鼻咽癌(nasopharyngeal carcinoma,NPC)大多数为低分化癌,恶性程度较高,易发生远处转移,是患者治疗失败和死亡的主要原因。鼻咽癌转移是一个多因素、多步骤相互作用的过程,涉及多种基因及其产物的相互作用,目前机制尚未完全阐明。本文就鼻咽癌转移相关分子标志物的研究进展做一综述。

1 EBV

1.1 结构与功能

EB病毒(eostein barr virus,EBV)是1964年Eostein和Barr在研究非洲儿童的恶性淋巴瘤时,从瘤细胞培养中发现的1种嗜人类B淋巴细胞的疱疹病毒,属于γ亚科。EB病毒是一种线状双链DNA病毒,由很多种不同的重复序列构成。在鼻咽癌患者体内,EB病毒主要表达EBER EBV核抗原1基因(EBNA-1)、潜伏膜蛋白基因(LMP-1和LMP-2)[1]。……

登录APP查看全文